Biotech startup Mogrify secures $3.7 million seed funding to accelerate and transform cell therapy via direct cellular conversion
Mogrify, a U.K. based biotech startup aiming to transform the future development of cell therapies, has raised $3.7 million seed funding to market novel IP and cell types generated using its proprietary direct cellular conversion platform, which will power the development and manufacture […]